Literature DB >> 25615535

The Nav1.2 channel is regulated by GSK3.

Thomas F James1, Miroslav N Nenov2, Norelle C Wildburger1, Cheryl F Lichti2, Jonathan Luisi2, Fernanda Vergara2, Neli I Panova-Electronova2, Carol L Nilsson2, Jai S Rudra2, Thomas A Green3, Demetrio Labate4, Fernanda Laezza5.   

Abstract

BACKGROUND: Phosphorylation plays an essential role in regulating voltage-gated sodium (Na(v)) channels and excitability. Yet, a surprisingly limited number of kinases have been identified as regulators of Na(v) channels. We posited that glycogen synthase kinase 3 (GSK3), a critical kinase found associated with numerous brain disorders, might directly regulate neuronal Na(v) channels.
METHODS: We used patch-clamp electrophysiology to record sodium currents from Na(v)1.2 channels stably expressed in HEK-293 cells. mRNA and protein levels were quantified with RT-PCR, Western blot, or confocal microscopy, and in vitro phosphorylation and mass spectrometry to identify phosphorylated residues.
RESULTS: We found that exposure of cells to GSK3 inhibitor XIII significantly potentiates the peak current density of Na(v)1.2, a phenotype reproduced by silencing GSK3 with siRNA. Contrarily, overexpression of GSK3β suppressed Na(v)1.2-encoded currents. Neither mRNA nor total protein expression was changed upon GSK3 inhibition. Cell surface labeling of CD4-chimeric constructs expressing intracellular domains of the Na(v)1.2 channel indicates that cell surface expression of CD4-Na(v)1.2 C-tail was up-regulated upon pharmacological inhibition of GSK3, resulting in an increase of surface puncta at the plasma membrane. Finally, using in vitro phosphorylation in combination with high resolution mass spectrometry, we further demonstrate that GSK3β phosphorylates T(1966) at the C-terminal tail of Na(v)1.2.
CONCLUSION: These findings provide evidence for a new mechanism by which GSK3 modulates Na(v) channel function via its C-terminal tail. GENERAL SIGNIFICANCE: These findings provide fundamental knowledge in understanding signaling dysfunction common in several neuropsychiatric disorders. Published by Elsevier B.V.

Entities:  

Keywords:  Confocal microscopy; Glycogen synthase kinase 3; Patch-clamp electrophysiology; Protein–protein interactions; Sodium channel

Mesh:

Substances:

Year:  2015        PMID: 25615535      PMCID: PMC4336163          DOI: 10.1016/j.bbagen.2015.01.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  50 in total

Review 1.  International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.

Authors:  William A Catterall; Alan L Goldin; Stephen G Waxman
Journal:  Pharmacol Rev       Date:  2005-12       Impact factor: 25.468

2.  Shearlet-based total variation diffusion for denoising.

Authors:  Glenn R Easley; Demetrio Labate; Flavia Colonna
Journal:  IEEE Trans Image Process       Date:  2008-12-16       Impact factor: 10.856

3.  Neuroscience: Channelopathies have many faces.

Authors:  Stephen G Waxman
Journal:  Nature       Date:  2011-04-14       Impact factor: 49.962

4.  Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels.

Authors:  Jun-Yang Lou; Fernanda Laezza; Benjamin R Gerber; Maolei Xiao; Kathryn A Yamada; Hali Hartmann; Ann Marie Craig; Jeanne M Nerbonne; David M Ornitz
Journal:  J Physiol       Date:  2005-09-15       Impact factor: 5.182

Review 5.  Regulation of sodium channel activity by phosphorylation.

Authors:  Todd Scheuer
Journal:  Semin Cell Dev Biol       Date:  2010-10-13       Impact factor: 7.727

6.  Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells.

Authors:  Toshihiko Yanagita; Toyoaki Maruta; Yasuhito Uezono; Shinya Satoh; Norie Yoshikawa; Takayuki Nemoto; Hideyuki Kobayashi; Akihiko Wada
Journal:  Neuropharmacology       Date:  2007-09-02       Impact factor: 5.250

7.  Chronic lithium treatment up-regulates cell surface Na(V)1.7 sodium channels via inhibition of glycogen synthase kinase-3 in adrenal chromaffin cells: enhancement of Na(+) influx, Ca(2+) influx and catecholamine secretion after lithium withdrawal.

Authors:  Toshihiko Yanagita; Toyoaki Maruta; Takayuki Nemoto; Yasuhito Uezono; Kiyotaka Matsuo; Shinya Satoh; Norie Yoshikawa; Tasuku Kanai; Hideyuki Kobayashi; Akihiko Wada
Journal:  Neuropharmacology       Date:  2009-05-30       Impact factor: 5.250

8.  The FGF14(F145S) mutation disrupts the interaction of FGF14 with voltage-gated Na+ channels and impairs neuronal excitability.

Authors:  Fernanda Laezza; Benjamin R Gerber; Jun-Yang Lou; Marie A Kozel; Hali Hartman; Ann Marie Craig; David M Ornitz; Jeanne M Nerbonne
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

9.  Molecular determinants of voltage-gated sodium channel regulation by the Nedd4/Nedd4-like proteins.

Authors:  Jean-Sébastien Rougier; Miguel X van Bemmelen; M Christine Bruce; Thomas Jespersen; Bruno Gavillet; Florine Apothéloz; Sophie Cordonier; Olivier Staub; Daniela Rotin; Hugues Abriel
Journal:  Am J Physiol Cell Physiol       Date:  2004-11-17       Impact factor: 4.249

10.  Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.

Authors:  Richard Scott Jope
Journal:  Front Mol Neurosci       Date:  2011-08-09       Impact factor: 5.639

View more
  20 in total

1.  CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability.

Authors:  Wei-Chun J Hsu; Federico Scala; Miroslav N Nenov; Norelle C Wildburger; Hannah Elferink; Aditya K Singh; Charles B Chesson; Tetyana Buzhdygan; Maveen Sohail; Alexander S Shavkunov; Neli I Panova; Carol L Nilsson; Jai S Rudra; Cheryl F Lichti; Fernanda Laezza
Journal:  FASEB J       Date:  2016-02-25       Impact factor: 5.191

2.  PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Wei-Chun J Hsu; Norelle C Wildburger; Sigmund J Haidacher; Miroslav N Nenov; Oluwarotimi Folorunso; Aditya K Singh; Brent C Chesson; Whitney F Franklin; Ibdanelo Cortez; Rovshan G Sadygov; Kelly T Dineley; Jay S Rudra; Giulio Taglialatela; Cheryl F Lichti; Larry Denner; Fernanda Laezza
Journal:  Exp Neurol       Date:  2017-05-15       Impact factor: 5.330

3.  Consequences of acute Nav1.1 exposure to deltamethrin.

Authors:  T F James; Miroslav N Nenov; Cynthia M Tapia; Marzia Lecchi; Shyny Koshy; Thomas A Green; Fernanda Laezza
Journal:  Neurotoxicology       Date:  2016-12-19       Impact factor: 4.294

4.  T2N as a new tool for robust electrophysiological modeling demonstrated for mature and adult-born dentate granule cells.

Authors:  Hermann Cuntz; Peter Jedlicka; Marcel Beining; Lucas Alberto Mongiat; Stephan Wolfgang Schwarzacher
Journal:  Elife       Date:  2017-11-22       Impact factor: 8.140

5.  Fibroblast Growth Factor 14 Modulates the Neurogenesis of Granule Neurons in the Adult Dentate Gyrus.

Authors:  Musaad A Alshammari; Tahani K Alshammari; Miroslav N Nenov; Federico Scala; Fernanda Laezza
Journal:  Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.590

6.  Glycogen synthase kinase 3 beta alters anxiety-, depression-, and addiction-related behaviors and neuronal activity in the nucleus accumbens shell.

Authors:  Elizabeth J Crofton; Miroslav N Nenov; Yafang Zhang; Federico Scala; Sean A Page; David L McCue; Dingge Li; Jonathan D Hommel; Fernanda Laezza; Thomas A Green
Journal:  Neuropharmacology       Date:  2017-01-23       Impact factor: 5.250

7.  Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulation.

Authors:  Roberto Piacentini; Domenica Donatella Li Puma; Cristian Ripoli; Maria Elena Marcocci; Giovanna De Chiara; Enrico Garaci; Anna Teresa Palamara; Claudio Grassi
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

8.  Glycogen synthase kinase 3 beta inhibitor SB216763 improves Kir2.1 expression after myocardia infraction in rats.

Authors:  Cheng Chang; Shu-Hui Wang; Li-Na Xu; Xue-Ling Su; Yi-Fan Zeng; Peng Wang; Li-Rong Zhang; Sheng-Na Han
Journal:  J Interv Card Electrophysiol       Date:  2021-02-20       Impact factor: 1.900

9.  Inhibition of AKT Signaling Alters βIV Spectrin Distribution at the AIS and Increases Neuronal Excitability.

Authors:  Jessica Di Re; Wei-Chun J Hsu; Cihan B Kayasandik; Nickolas Fularczyk; T F James; Miroslav N Nenov; Pooran Negi; Mate Marosi; Federico Scala; Saurabh Prasad; Demetrio Labate; Fernanda Laezza
Journal:  Front Mol Neurosci       Date:  2021-06-30       Impact factor: 5.639

10.  Quantitative phosphoproteomic analysis of the molecular substrates of sleep need.

Authors:  Zhiqiang Wang; Jing Ma; Chika Miyoshi; Yuxin Li; Makito Sato; Yukino Ogawa; Tingting Lou; Chengyuan Ma; Xue Gao; Chiyu Lee; Tomoyuki Fujiyama; Xiaojie Yang; Shuang Zhou; Noriko Hotta-Hirashima; Daniela Klewe-Nebenius; Aya Ikkyu; Miyo Kakizaki; Satomi Kanno; Liqin Cao; Satoru Takahashi; Junmin Peng; Yonghao Yu; Hiromasa Funato; Masashi Yanagisawa; Qinghua Liu
Journal:  Nature       Date:  2018-06-13       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.